Rituxan® (rituximab)
for Arthritis Rheumatoid

Rituxan (rituximab) is a monoclonal antibody given by IV infusion that targets B cells to treat cancers and autoimmune conditions. It is used for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris. By destroying B cells, Rituxan helps manage cancer, inflammation, and immune-related diseases.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Rheumatoid